ConductScience.org, home

Paper5225072

Osteogenic sarcoma. A study of six hundred cases.

Dahlin DC and 1 other. J Bone Joint Surg Am, 1967. Cited by 535 papers, by iCite.

Cite this record

ConductScience Library. Osteogenic sarcoma. A study of six hundred cases. Papers, record 5225072. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5225072

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Osteogenic sarcoma. A study of six hundred cases.
PubMed
Journal
J Bone Joint Surg Am
PubMed
Year
1967
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
535
iCite
Revised in PubMed
2016-05-12
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dahlin DCD C
2Coventry MBM B

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
OsteosarcomaMajor topic
Adolescent
Adult
Child
Female
Follow-Up Studies
Humans
Lung Neoplasms
Male
Middle Aged
Neoplasm Metastasis
Osteitis Deformans
Osteoma
Radiotherapy

Source PubMed

Download CSV of topics

Cited by80

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 535 citations.

PMIDTitleJournalYearIn PapersSource
40850163Diagnostic challenges and therapeutic approaches in pediatric osteosarcoma: A case report.Int J Surg Case Rep2025https://conductscience.org/library/papers/40850163PubMed
38236058A Bibliometric Analysis of the 500 Most Cited Papers in Orthopaedic Oncology.J Am Acad Orthop Surg Glob Res Rev2024https://conductscience.org/library/papers/38236058PubMed
38213875Chondroblastic osteosarcoma.Autops Case Rep2023https://conductscience.org/library/papers/38213875PubMed
37873526Descriptive Epidemiology and Survival Rate of Osteosarcoma: The First National Population-Based Study in the Middle East (2008-2014).Arch Bone Jt Surg2023https://conductscience.org/library/papers/37873526PubMed
37081847Integrated gene network analysis sheds light on understanding the progression of Osteosarcoma.Front Med (Lausanne)2023https://conductscience.org/library/papers/37081847PubMed
36113969Canine Idiopathic Arteriopathy, Appendicular Bone Infarcts, and Neoplastic Transformation of Bone Infarcts in 108 Dogs (Canis lupus familiaris).Comp Med2022https://conductscience.org/library/papers/36113969PubMed
35602295Development and Validation of Nomogram-Based Prognosis Tools for Patients with Extremity Osteosarcoma: A SEER Population Study.J Oncol2022https://conductscience.org/library/papers/35602295PubMed
35192571Characteristics, Management, and Outcomes of Patients With Osteosarcoma: An Analysis of Outcomes From the National Cancer Database.J Am Acad Orthop Surg Glob Res Rev2022https://conductscience.org/library/papers/35192571PubMed
35141071Osteosarcoma of the Right Lower Femur With Breast and Axillary Lymph Node Metastasis: A Rare Case Presentation.Cureus2021https://conductscience.org/library/papers/35141071PubMed
35004381Pseudocystic Osteosarcoma: A Potential Diagnostic Pitfall - Case Report.J Orthop Case Rep2021https://conductscience.org/library/papers/35004381PubMed
34899138Primary osteosarcoma of the sphenoid wing in a middle-aged woman with extensive intracranial extension: A case report.J Taibah Univ Med Sci2021https://conductscience.org/library/papers/34899138PubMed
33936058Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies.Front Immunol2021https://conductscience.org/library/papers/33936058PubMed
33880674Update on Osteosarcoma.Curr Oncol Rep2021https://conductscience.org/library/papers/33880674PubMed
32850032Clinical and Oncological Outcome of Chondroblastic Osteosarcoma: A Single Institutional Experience.Indian J Orthop2020https://conductscience.org/library/papers/32850032PubMed
31901872The CD24+ cell subset promotes invasion and metastasis in human osteosarcoma.EBioMedicine2020https://conductscience.org/library/papers/31901872PubMed
30604867Prognostic scoring system for osteosarcoma using network-regularized high-dimensional Cox-regression analysis and potential therapeutic targets.J Cell Physiol2019https://conductscience.org/library/papers/30604867PubMed
29850522Identification of Key Genes and miRNAs in Osteosarcoma Patients with Chemoresistance by Bioinformatics Analysis.Biomed Res Int2018https://conductscience.org/library/papers/29850522PubMed
29494553Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma.Int J Mol Sci2018https://conductscience.org/library/papers/29494553PubMed
29492676Primary Osteosarcoma in the Elderly Revisited: Current Concepts in Diagnosis and Treatment.Curr Oncol Rep2018https://conductscience.org/library/papers/29492676PubMed
29278618Team Approach: Osteosarcoma of the Distal Part of the Femur in Adolescents.JBJS Rev2017https://conductscience.org/library/papers/29278618PubMed

See all 80 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5225072

GET https://conductscience.org/api/papers/v1/5225072/cited_by?page=2